Invesco Ltd. Acquires 81,275 Shares of Avanos Medical, Inc. (NYSE:AVNS)

Invesco Ltd. lifted its stake in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 28.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 363,738 shares of the company's stock after acquiring an additional 81,275 shares during the period. Invesco Ltd. owned 0.79% of Avanos Medical worth $5,791,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Barclays PLC boosted its holdings in Avanos Medical by 446.2% during the third quarter. Barclays PLC now owns 96,194 shares of the company's stock worth $2,311,000 after buying an additional 78,583 shares in the last quarter. Envestnet Asset Management Inc. boosted its position in Avanos Medical by 15.8% during the 4th quarter. Envestnet Asset Management Inc. now owns 128,567 shares of the company's stock worth $2,047,000 after acquiring an additional 17,504 shares during the period. Vanguard Group Inc. grew its position in Avanos Medical by 0.4% during the fourth quarter. Vanguard Group Inc. now owns 5,339,778 shares of the company's stock valued at $85,009,000 after purchasing an additional 19,476 shares in the last quarter. JPMorgan Chase & Co. grew its holdings in shares of Avanos Medical by 6.9% during the 3rd quarter. JPMorgan Chase & Co. now owns 69,571 shares of the company's stock valued at $1,672,000 after acquiring an additional 4,472 shares in the last quarter. Finally, Jane Street Group LLC increased its position in Avanos Medical by 35.8% in the 3rd quarter. Jane Street Group LLC now owns 65,650 shares of the company's stock worth $1,578,000 after purchasing an additional 17,306 shares during the last quarter. 95.17% of the stock is currently owned by institutional investors.

Avanos Medical Stock Performance

Shares of NYSE:AVNS traded down $0.04 during trading on Thursday, hitting $12.51. 55,445 shares of the stock were exchanged, compared to its average volume of 337,535. The company's fifty day simple moving average is $13.83 and its 200-day simple moving average is $16.58. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22. The company has a market capitalization of $575.50 million, a price-to-earnings ratio of 36.81 and a beta of 1.15. Avanos Medical, Inc. has a 1-year low of $11.84 and a 1-year high of $25.36.

Avanos Medical (NYSE:AVNS - Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The company reported $0.43 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.40 by $0.03. The company had revenue of $179.60 million during the quarter, compared to analysts' expectations of $177.23 million. Avanos Medical had a net margin of 2.30% and a return on equity of 4.70%. Sell-side analysts expect that Avanos Medical, Inc. will post 1.32 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised Avanos Medical from a "hold" rating to a "buy" rating in a research report on Wednesday, March 19th.

Insider Buying and Selling

In related news, SVP Kerr Holbrook sold 7,000 shares of the business's stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $15.25, for a total value of $106,750.00. Following the sale, the senior vice president now directly owns 82,047 shares of the company's stock, valued at approximately $1,251,216.75. The trade was a 7.86 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 2.64% of the stock is owned by corporate insiders.

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.